Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 8Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 6Neoplasm Metastasis 2Metastatic Hormone-Sensitive Prostate Cance 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Advanced Prostate Carcinoma 1

Interventions

Blood Specimen Collection 7Drug Therapy 6Surveys and Questionnaires 5Radiotherapy 5Radiosurgery 5Docetaxel 5Therapeutics 4Specimen Handling 4Immunotherapy 4Hepatectomy 4exemestane 3enzalutamide 3apalutamide 3Trastuzumab 3Hematologic Tests 3Data Collection 3Biopsy 3Biological Assay 3Anastrozole 3Abiraterone Acetate 3trastuzumab deruxtecan 2palbociclib 2darolutamide 2abiraterone 2abemaciclib 2Wearable Electronic Devices 2Triptorelin Pamoate 2Tamoxifen 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Neoplasm Metastasis × abiraterone × Clear all
NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Pfizer

Completed
1,083 enrolled 29 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT05188911 2022-01-12

Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial

Fudan University

Unknown
30 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡